Please write a prescription for fusidic acid 2% ointment (Fucidine).

Prescription for Fusidic Acid 2% Ointment (Fucidine)

For minor skin infections such as impetigo and secondarily infected skin lesions, fusidic acid 2% ointment (Fucidine) should be applied topically 2-3 times daily for 7-14 days maximum to the affected area.

Standard Prescription Format

Patient Name: [Insert patient name]
Date: [Insert date]

Rx: Fusidic Acid 2% Ointment (Fucidine)

• Sig: Apply thin layer to affected area 2-3 times daily
• Duration: 7-14 days (do not exceed 14 days)
• Quantity: 15-30 grams (depending on affected area size)
• Refills: 0

Instructions for patient:

• For external use only 1
• Do not use in eyes or rectum 1
• Wash hands before and after application
• Clean affected area gently before applying
• If condition worsens or persists beyond 7 days, consult physician 1

Clinical Context and Rationale

Appropriate Indications

Fusidic acid is specifically indicated for:

• Primary skin infections: Impetigo, folliculitis, furunculosis, infected traumatic wounds 2
• Secondarily infected lesions: Infected eczema, ulcers, lacerations 3, 4
• Pediatric minor skin infections 3, 4

The IDSA guidelines specifically recommend mupirocin 2% for children with minor skin infections 3, 4, but fusidic acid represents an effective alternative with excellent anti-staphylococcal activity 5, 6.

Key Advantages of Fusidic Acid

• Superior skin penetration: Unlike gentamicin or mupirocin, fusidic acid achieves high antimicrobial concentrations at deep skin layers on both intact and damaged epidermis 5
• Potent anti-staphylococcal activity: Highly effective against S. aureus (including methicillin-resistant strains), S. epidermidis, and Streptococcus pyogenes 5, 6, 2
• Low sensitization risk: Minimal contact dermatitis potential due to large steric molecular structure 5
• Low resistance development: When restricted to ≤14 days of therapy 6

Critical Prescribing Caveats

Duration limitation is essential: Restrict therapy to maximum 14 days to minimize resistance development 6. This is the single most important prescribing consideration.

Not first-line for all SSTIs: For purulent abscesses, incision and drainage is the primary treatment 4. Antibiotics (topical or oral) are adjunctive and indicated only when:

• Multiple lesions present
• Severe local infection or systemic signs
• Immunocompromised patient
• Failed initial drainage alone 4

Consider combination therapy for infected eczema: When both inflammation and infection are present, fusidic acid combined with 1% hydrocortisone or 0.1% betamethasone addresses both components effectively 6, 7. However, this requires a different prescription for the combination product.

When NOT to Use Fusidic Acid Alone

For complicated SSTIs (deeper infections, major abscesses, cellulitis, infected ulcers/burns), systemic antibiotics are required 3, 4:

• Outpatient empiric MRSA coverage: Clindamycin, TMP-SMX, doxycycline, or linezolid orally 3, 4
• Hospitalized patients: IV vancomycin, linezolid, daptomycin, or telavancin 3, 4

For non-purulent cellulitis, empirical therapy should target β-hemolytic streptococci with a β-lactam antibiotic, not topical fusidic acid 4.

Application Technique

• Apply thin layer to affected area only
• Avoid excessive amounts (200-400g per week for twice-daily whole body application is excessive for localized infections) 7
• May cover with clean, dry bandage if needed 3
• Ensure good hand hygiene before and after application 3

Monitoring and Follow-up

• Reassess at 7 days: If no improvement or worsening, obtain cultures and consider systemic antibiotics 3, 4
• Stop treatment once lesions clear, even if before 14 days
• Do not continue beyond 14 days to prevent resistance 6